Barry D Quart

CIK 1384243 · Chief Executive Officer · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$869.6K

Companies

4

Total Filings

80

Lifetime Open-Market Net

-$15.37M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KNSA Director 15,345 $51.89 $796.3K -$3.87M 16 2026-06-02
HRTX Chief Executive Officer 183,208 $0.40 $73.3K -$7.45M 29 2023-01-20
SYNAGEVA BIOPHARMA CORP (GEVA) Delisted Director $0 5 2015-06-23
Ardea Biosciences, Inc./DE (RDEA) Delisted President and CEO 2,500 -$4.05M 20 2012-06-20

Recent Filings · Page 3 of 8

80 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-07-15 HRTX Mixed +4,211 $8.3K EDGAR
2021-06-30 KNSA Grant (A) $0 EDGAR
2021-04-15 HRTX Mixed +3,283 -$16.0K EDGAR
2021-01-15 HRTX Mixed +2,683 -$17.5K EDGAR
2020-10-15 HRTX Mixed +1,158 $14.0K EDGAR
2020-07-02 KNSA Grant (A) $0 EDGAR
2019-12-23 HRTX Grant (A) $0 EDGAR
2019-10-04 HRTX Mixed +5,377 $94.8K EDGAR
2019-05-30 KNSA Grant (A) $0 EDGAR
2018-12-18 HRTX Grant (A) $0 EDGAR
Showing 2130 of 80
Page 3 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.